Intravenous Immunoglobulin Versus Plasmapheresis in Patients Admitted for Myasthenic Crisis-Single Hospital Experience (P1-11.031)
We undertook a retrospective analysis of patients admitted to a 700 bed teaching hospital between July 2020 and January 2024 with an aim of evaluating utilization of intravenous immunoglobulin (IVIG) for myasthenic crisis (MC), percentage of patients treated with IVIG who required escalation of care to plasma exchange (PLEX),patient characteristics to help guide initial management selection for patients in MC and the impact of initial treatment choice on clinical outcomes.
Authors
- Ratna Bhavaraju‐Sanka
- María Eugénia Mata (ORCID: https://orcid.org/0000-0003-0461-1338)
- Colleen Barthol (ORCID: https://orcid.org/0000-0002-3239-947X)
- J. Jacobs
Institutions
- The University of Texas at San Antonio Health Science Center (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211660
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00